Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The duodenal mucosal bicarbonate secretion.

Markus Sjöblom1

  • 1Department of Neuroscience, Division of Physiology, Uppsala University, Uppsala, Sweden. markus.sjoblom@fysiologi.uu.se

Upsala Journal of Medical Sciences
|August 4, 2005
PubMed
Summary

Melatonin significantly boosts duodenal bicarbonate secretion, a key defense against stomach acid. This hormone also influences calcium signaling in duodenal cells, aiding mucosal protection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of PERK signaling suppresses tumor progression and blocks GP73-GRP78-dependent stromal activation in hepatocellular carcinoma.

Neoplasia (New York, N.Y.)·2026
Same author

Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients.

Therapeutic advances in medical oncology·2026
Same author

The In Vivo Effect of Amorphous Drug Nanoprecipitates on the Intestinal Absorption of the PROTACs ARV-110 (Bavdeglutamide) and ARV-471 (Vepdegestrant).

Molecular pharmaceutics·2026
Same author

Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling.

FEBS open bio·2026
Same author

A comparative study of idarubicin and doxorubicin in a chemically-induced in vivo mouse model for hepatocellular carcinoma.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Statin-mediated protection in chemotherapy-induced intestinal and cardiac toxicity: current perspectives.

European journal of pharmacology·2025

Area of Science:

  • Gastroenterology
  • Neuroendocrinology
  • Cell Physiology

Background:

  • The duodenal mucosa faces constant threats from gastric acid.
  • Duodenal bicarbonate secretion is a critical mucosal defense mechanism.
  • The roles of the central nervous system and melatonin in this process require further elucidation.

Purpose of the Study:

  • To investigate the influence of the central nervous system and melatonin on duodenal bicarbonate secretion in rats.
  • To examine the effects of melatonin on intracellular calcium signaling in human and rat duodenal enterocytes.
  • To understand the interplay between neural pathways, melatonin, and duodenal alkaline secretion.

Main Methods:

  • In vivo studies in anesthetized rats using pharmacological agents and surgical interventions (vagal/sympathetic nerve ligation).
  • In vitro studies on isolated human and rat duodenal enterocytes to assess calcium signaling.
  • Measurement of duodenal bicarbonate secretion and intracellular calcium levels.

Main Results:

  • Melatonin potently stimulates duodenal bicarbonate secretion and is involved in acid-induced secretion.
  • Central nervous system stimulation via phenylephrine releases intestinal melatonin, increasing alkaline secretion fourfold.
  • Melatonin triggers calcium release from intracellular stores and extracellular influx in enterocytes.
  • Fasting down-regulates responses to orexin-A and bethanechol but not melatonin or vasoactive intestinal polypeptide.

Conclusions:

  • Melatonin is a significant stimulator of duodenal bicarbonate secretion, acting via calcium signaling pathways.
  • Central neural pathways modulate duodenal alkaline secretion through melatonin release.
  • Melatonin represents a potential therapeutic target for protecting the duodenal mucosa.

Related Experiment Videos